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Complementary and alternative medicine (CAM) is a big issue for cancer patients who may feel tempted
to use one of the many therapies on offer. In particular, alternative cancer ‘‘cures’’ are being promoted to
vulnerable patients. None of these ‘‘cures’’ have been shown to do what they promise, and the very
notion of an alternative cancer ‘‘cure’’ is a contradiction in terms. Yet CAM can play an important role in
oncology, and that is in supportive and palliative care. Several treatments can decrease the side-effects of
cancer drugs or improve quality of life in other ways.
 2009 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.Precise ﬁgures vary, but most experts agree: a large proportion
of cancer patients use some form of CAM,1 and many fail to share
this fact with their oncology treatment team.2 Thus patients look
for information themselves and ﬁnd data which are frequently
misleading.3,4 They are therefore at risk of using ineffective or
harmful treatments,5 and consequently outcomes may suffer.6
Many oncologists are thus rightly concerned about ‘‘alternative’’
medicine. But the issue of CAM and cancer is complex and fortu-
nately not all negative.
In this article, I will try to outline the difference between
alternative cancer ‘‘cures’’ and complementary cancer care. The
former is the ‘‘ugly face’’ authoritatively described by M Baum in
the previous issue,7 and the latter might be the ‘‘kind face’’ of CAM.1. Alternative cancer ‘‘cures’’
There are thousands of books, articles and websites promoting
this or that alternative cancer ‘‘cure’’. Examples include mistletoe,
shark cartilage, laetrile and Essiac but a full list would be vast. We
have systematically reviewed the evidence for and against those
treatments that have been submitted to clinical trials (the minority
of the full list) and arrived at the conclusion that none of them are
supported by good evidence.8 On the contrary, they put cancer
patients at risk.62.
ciates Ltd. Published by Elsevier LtThe mere notion of an alternative cancer ‘‘cure’’ is implausible:
as soon as this or that treatment shows some promise, it would
attract the attention of conventional scientists and be systemati-
cally investigated. As a result, we might generate an effective and
scientiﬁcally tested therapy. In other words, the treatment in
question would soon be entirely mainstream. The idea that alter-
native cancer ‘‘cures’’ might exist, suggests that conventional
medicine ignores encouraging data simply because they do not
originate from its own sphere. This, to the best of my knowledge, is
not the case. On the contrary, conventional scientists have always
searched for clues from outside their own sphere to ﬁnd effective
treatments and, occasionally, such endeavours have been success-
ful. Many of our modern cancer drugs originate from plants, for
example.
In conclusion, the notion of alternative cancer ‘‘cures’’ is danger-
ously misleading. It is, of course, understandable that desperate
cancer patients look for any option that promises help.
But it is unethical to make false promises and to exploit the
desperation of vulnerable patients.2. Complementary cancer care
All this, however, does notmean that CAMdoes not have a role at
all in oncology. There is growing evidence to suggest that some
forms of CAM are helpful in supportive and palliative cancer care.
The aim of this approach is clearly not to change the natural history
of the disease, but to ease the suffering of patients. The comple-
mentary therapies in question are used as an adjunct tod. All rights reserved.
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decreasing the adverse effects of anti-cancer treatments or through
alleviating the symptoms of cancer through improving the general
well-being of the patient.
We have systematically reviewed the trial data relating to
complementary medicine for supportive and palliative cancer care
and found encouraging evidence for a wide range of treatments,
e.g:
 Acupuncture for alleviating chemotherapy-induced nausea and
vomiting.
 Acupressure for alleviating chemotherapy-induced nausea and
vomiting.
 Aromatherapy to improve well-being.
 Calendula for preventing radiation-induced dermatitis.
 Co-enzyme Q10 to reduce therapy-induced adverse effects.
 Exercise to reduce fatigue and nausea.
 Ginseng to reduce fatigue.
 Hypnotherapy to control pain, nausea and vomiting.
 Massage therapy to improve well-being.
 Music therapy to reduce mood disturbances.
 Relaxation to control pain and reduce fatigue.3. Conclusions
CAM for cancer is an issue with two sides. The ugly face is
characterised by the deception of vulnerable patients who are led
to believe that they might get cured by bogus alternative therapies.
The kind face of CAM is characterised by the attempt of improving
the quality of life of suffering patients with treatments thatalleviate their symptoms. Sadly, the ugly face is the one that often
shows itself more prominently than the kind one. Healthcare
practitioners should be aware of the two faces of CAM and inform
their patients accordingly.
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